Clinical trial

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer

NCT00760370

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-12-01

PhasePHASE2

Study timeline

Study start (unknown)2008-12-01Date precision: month

Registry last updated2011-12-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Myelomaunresolved

Breast Cancerunresolved

Interventions

Zoledronic AcidDRUG · verified · RxNorm: zoledronic acid

Sponsors & collaborators

Vejle Hospitallead sponsor

Odense University Hospitalcollaborator

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00760370 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.